These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37277195)

  • 21. Innovative vaccine approaches-a Keystone Symposia report.
    Cable J; Rappuoli R; Klemm EJ; Kang G; Mutreja A; Wright GJ; Pizza M; Castro SA; Hoffmann JP; Alter G; Carfi A; Pollard AJ; Krammer F; Gupta RK; Wagner CE; Machado V; Modjarrad K; Corey L; B Gilbert P; Dougan G; Lurie N; Bjorkman PJ; Chiu C; Nemes E; Gordon SB; Steer AC; Rudel T; Blish CA; Sandberg JT; Brennan K; Klugman KP; Stuart LM; Madhi SA; Karp CL
    Ann N Y Acad Sci; 2022 May; 1511(1):59-86. PubMed ID: 35029310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
    Ford A; Hwang A; Mo AX; Baqar S; Touchette N; Deal C; King D; Earle K; Giersing B; Dull P; Hall BF
    Vaccine; 2023 Mar; 41(11):1799-1807. PubMed ID: 36803897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building global vaccine manufacturing capacity: Spotlight on Africa.
    Rubin Thompson LJ; Grubo M; Veller M; Badenhorst RH; Nott J; Debruyne L; Makadzange T; Nicolaou S; Stanberry L; Sall A; James WG
    Vaccine; 2023 Jun; 41(27):4050-4056. PubMed ID: 37173266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
    Chan IL; Mowson R; Alonso JP; Roberti J; Contreras M; Velandia-González M
    Vaccine; 2022 Mar; 40(13):1977-1986. PubMed ID: 35221122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator.
    Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 vaccines: what do we know so far?
    Dhillon P; Altmann D; Male V
    FEBS J; 2021 Sep; 288(17):4996-5009. PubMed ID: 34288409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 vaccinology landscape in Africa.
    Baptista S; Naidoo S; Suliman S; Nepolo E; Kanoi BN; Gitaka J; Blessing OM; Enany S
    Front Immunol; 2022; 13():955168. PubMed ID: 36544758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning.
    Johnson RA; White RC; Disbrow GL
    Hum Vaccin Immunother; 2022 Nov; 18(6):2129930. PubMed ID: 36302122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
    Shivji R; Conocchia R; Korakianiti E; Jekerle V
    Vaccine; 2022 Sep; 40(38):5539-5541. PubMed ID: 35779964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap.
    Borges LC; Zeferino de Menezes H; Crosbie E
    Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. US public investment in development of mRNA covid-19 vaccines: retrospective cohort study.
    Lalani HS; Nagar S; Sarpatwari A; Barenie RE; Avorn J; Rome BN; Kesselheim AS
    BMJ; 2023 Mar; 380():e073747. PubMed ID: 36858453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8.
    Nhamo G; Sibanda M
    Glob Public Health; 2021 Oct; 16(10):1537-1558. PubMed ID: 34105432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa.
    Dube A; Egieyeh S; Balogun M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.
    Kholina K; Harmon SHE; Graham JE
    PLoS One; 2022; 17(12):e0279929. PubMed ID: 36584230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making.
    Liang CK; Lee WJ; Peng LN; Meng LC; Hsiao FY; Chen LK
    Clin Geriatr Med; 2022 Aug; 38(3):605-620. PubMed ID: 35868676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic.
    Arguedas-Ramírez G
    Ann Glob Health; 2022; 88(1):87. PubMed ID: 36311897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.